Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3

Adenosine is a regulatory molecule with widespread physiological effects in almost every cells and acts as a potent regulator of cell growth. Adenosine has been shown to inhibit cell growth and induce apoptosis in the several cancer cells via caspase activation and Bcl-2/Bax pathway. The present study was designed to understand the mechanism underlying adenosine-induced apoptosis in the OVCAR-3 human ovarian cancer cells. MTT viability, BrdU and cell counting assays were used to study the cell proliferation effect of adenosine in presence of adenosine deaminase inhibitor and the nucleoside transporter inhibitor. Cell cycle analysis, propidium iodide and annexin V staining, caspase-3 activity assay, cyclinD1, Cdk4, Bcl-2 and Bax protein expressions were assessed to detect apoptosis. Adenosine significantly inhibited cell proliferation in a concentration-dependent manner in OVCAR-3 cell line. Adenosine induced cell cycle arrest in G0/G1 phase via Cdk4/cyclinD1-mediated pathway. Adenosine induced apoptosis, which was determined by Annexin V-FITC staining and increased sub-G1 population. Moreover, down-regulation of Bcl-2 protein expression, up-regulation of Bax protein expression and activation of caspase-3 were observed in response to adenosine treatment. The results of this study suggest that extracellular adenosine induced G1 cell cycle arrest and apoptosis in ovarian cancer cells via cyclinD1/ Cdk4 and Bcl-2/Bax pathways and caspase-3 activation. These data might suggest that adenosine could be used as an agent for the treatment of ovarian cancer.

[1]  M. Rathbone,et al.  Mechanisms of apoptosis induced by purine nucleosides in astrocytes , 2002, Glia.

[2]  S. Maddika,et al.  Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor‐positive and ‐negative human breast cancer cells via the intrinsic pathway , 2005, Cell proliferation.

[3]  D. Hoyer,et al.  P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1 beta-converting enzyme. , 1994, Journal of Medicinal Chemistry.

[4]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[5]  K. Klotz,et al.  Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. , 2002, The Journal of investigative dermatology.

[6]  C. Simioni,et al.  Adenosine receptors and cancer. , 2011, Biochimica et biophysica acta.

[7]  Y. Tanaka,et al.  Apoptosis induced by adenosine in human leukemia HL-60 cells. , 1994, Experimental cell research.

[8]  Ling-Fei Wu,et al.  Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells , 2006, Acta Pharmacologica Sinica.

[9]  L. Jeong,et al.  Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells. , 2008, Cancer letters.

[10]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[11]  S. Ghavami,et al.  Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions , 2004, Journal of leukocyte biology.

[12]  H. Granger,et al.  Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. , 1988, The American journal of physiology.

[13]  M. Aghaei,et al.  Diagnostic value of adenosine deaminase activity in benign and malignant breast tumors. , 2010, Archives of medical research.

[14]  I. Biaggioni,et al.  Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. , 2001, Investigative ophthalmology & visual science.

[15]  C. Fiorentini,et al.  The A3 Adenosine Receptor Induces Cytoskeleton Rearrangement in Human Astrocytoma Cells via a Specific Action on Rho Proteins , 2001, Annals of the New York Academy of Sciences.

[16]  M. Aghaei,et al.  Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway , 2011, Journal of Cancer Research and Clinical Oncology.

[17]  J. Sedivy,et al.  Analysis of cell cycle phases and progression in cultured mammalian cells. , 2007, Methods.

[18]  K. Klotz,et al.  Adenosine receptors and cancer. , 2011, Handbook of experimental pharmacology.

[19]  F. Karami-Tehrani,et al.  Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors. , 2007, Oncology research.

[20]  Jing-ping Ou-yang,et al.  Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine , 2005, Acta Pharmacologica Sinica.

[21]  W. Chazin,et al.  S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3 , 2010, Cell Research.

[22]  M. Aghaei,et al.  Adenosine induces cell‐cycle arrest and apoptosis in androgen‐dependent and ‐independent prostate cancer cell lines, LNcap‐FGC‐10, DU‐145, and PC3 , 2012, The Prostate.

[23]  T. Nakano,et al.  Adenosine suppresses CW2 human colonic cancer growth by inducing apoptosis via A(1) adenosine receptors. , 2010, Cancer letters.

[24]  Adenosine triphosphate induces activation of caspase-3 in apoptosis of human granulosa-luteal cells. , 2002, Endocrine journal.

[25]  F. Karami-Tehrani,et al.  Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. , 2003, Clinical biochemistry.

[26]  L. Hartmann,et al.  Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer , 2007, Journal of cellular biochemistry.

[27]  K. Jacobson,et al.  Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis , 2001, Journal of Molecular Neuroscience.

[28]  A. Multani,et al.  Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor. , 2000, European journal of cancer.

[29]  K. Varani,et al.  Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: Focus on the A3 adenosine subtype , 2007, Journal of cellular physiology.

[30]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[31]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[32]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[33]  S. Park,et al.  Thymidine-dependent attenuation of the mitochondrial apoptotic pathway in adenosine-induced apoptosis of HL-60 cells , 2001, Journal of Cancer Research and Clinical Oncology.

[34]  K. Jacobson,et al.  Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. , 1996, Biochemical and biophysical research communications.

[35]  H. Wiendl,et al.  Biphasic cytotoxic mechanism of extracellular ATP on U-937 human histiocytic leukemia cells: involvement of adenosine generation. , 2001, Biochimica et biophysica acta.

[36]  P. Fishman,et al.  Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor , 2001, Journal of cellular physiology.

[37]  L. Hartmann,et al.  Current management strategies for ovarian cancer. , 2007, Mayo Clinic proceedings.

[38]  L. Chiang,et al.  Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. , 2004, Life sciences.

[39]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[40]  Saeid Ghavami,et al.  S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase‐dependent pathway , 2008, Journal of leukocyte biology.